Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2011
05/25/2011EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
05/25/2011EP1372684B1 Methods of reducing beta-amyloid polypeptides
05/25/2011EP1317454B1 Caspase inhibitors and uses thereof
05/25/2011EP1183330B1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
05/25/2011EP0947584B1 Loxoprofen-containing preparation for external use
05/25/2011CN1730494B Cobratide modified by polyethylene glycol, its preparation method and uses
05/25/2011CN1416352B Outer membrane vesicle (OMV) vaccine comprising N. Meningitidis serogroup B outer membrane
05/25/2011CN102076704A Synthesis of timosaponin BII
05/25/2011CN102076694A 5, 6, 7, 8-tetrahydro-imidazo[1, 5-a]pyrazine compounds
05/25/2011CN102076693A Substituted tricyclic derivatives against neurodegenerative diseases
05/25/2011CN102076692A Triazolo [4, 5-D] pyramidine derivatives and their use as purine receptor antagonists
05/25/2011CN102076684A Substituted pyrimidin-4-one derivatives
05/25/2011CN102076683A Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives
05/25/2011CN102076682A Five-membered ring compound
05/25/2011CN102076679A Novel tetramethyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
05/25/2011CN102076678A Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors
05/25/2011CN102076672A Novel five-membered ring compound
05/25/2011CN102076671A Triazole derivative or salt thereof
05/25/2011CN102076669A Substituted n-oxide pyrazine derivatives
05/25/2011CN102076667A Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
05/25/2011CN102076650A Carboxylic acid compound
05/25/2011CN102076349A Withania somnifera plant extract and method for manufacturing thereof
05/25/2011CN102076341A Substituted pyrimidone derivatives
05/25/2011CN102076340A Transdermal patch containing fentanyl or salt thereof
05/25/2011CN102076339A Use of epothelone d in treating tau-associated diseases including alzheimer's disease
05/25/2011CN102070715A Human antibodies that bind human TNF alpha
05/25/2011CN102070605A Imatinib mesylate polymorph and pharmaceutical composition
05/25/2011CN102070597A Amide alkaloid and preparation method thereof
05/25/2011CN102070582A 2, 3-dihydroxy cinnamomum lactone derivative and application thereof
05/25/2011CN102068697A Opiates painkiller and opiate receptor antagonist-containing medicinal composition
05/25/2011CN102068656A Quality control method for traditional Chinese medicinal preparation epilepsy pills
05/25/2011CN102068654A Chinese medicinal preparation for abandoning drug habits and soothing nerves
05/25/2011CN102068650A Chinese herbal medicine for treatment of dysmenorrhea
05/25/2011CN102068637A Chinese medicine formula for treatment of migraine
05/25/2011CN102068634A Externally applied ironing moxibustion clay for human body and manufacturing method thereof
05/25/2011CN102068624A Traditional Chinese medicine for treatment of hemicrania
05/25/2011CN102068623A Traditional Chinese medicine for treatment of headache
05/25/2011CN102068595A New application of Chinese medicinal composition to treatment of vascular dementia
05/25/2011CN102068593A Traditional Chinese medicine for treatment of insomnia
05/25/2011CN102068565A Preparation method of pharmaceutical composition with anti-anxiety effect
05/25/2011CN102068555A Medicinal composition for improving sleep and preparation method thereof
05/25/2011CN102068547A Medicine for treating qi stagnancy and blood stasis intractable insomnia
05/25/2011CN102068530A Traditional Chinese medicine for preventing and treating vascular dementia
05/25/2011CN102068447A Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases
05/25/2011CN102068434A Application of 4-(cyclohexyl)-aminoquinazoline compounds
05/25/2011CN102068427A Use of compound
05/25/2011CN102068424A Brain atrophy treating medicament prepared from active ingredient of radish seed
05/25/2011CN102068423A Use of active ingredient from radish seed for preparing medicament for treating senile dementia
05/25/2011CN102068414A Levetiracetam sustained-release tablets and preparation method thereof
05/25/2011CN102068169A Medicinal pillow for improving sleep
05/25/2011CN101697977B Deproteinized calf blood extractive injection and preparation method thereof
05/25/2011CN101647795B Application of Xyloketal B in preparation of medicine for treating radical damage disease
05/25/2011CN101518575B Traditional Chinese medicine for treating diabetic insomnia
05/25/2011CN101513510B Traditional Chinese medicine compound preparation for treating spinal cord injury and method for preparing same
05/25/2011CN101491625B Sedative anti-insomnia oral medicine
05/25/2011CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
05/25/2011CN101461879B Plaster for treating neck, spine, protrusion of lumbar vertebral disc, hyperosteogeny, arthralgia and myalgia
05/25/2011CN101440079B Process for the preparation of racemic citalopram and/or s- or r-citalopram
05/25/2011CN101439131B Chinese medicinal composition for treating phonosensitive nerve deafness and use thereof
05/25/2011CN101402636B Propellane compounds, preparation method and application thereof
05/25/2011CN101374814B Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
05/25/2011CN101361839B Quality control detection method of Xuefu Zhuyu oral liquid
05/25/2011CN101297867B Cigarette for quitting drug and preparation thereof
05/25/2011CN101273046B Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
05/25/2011CN101259134B New pharmaceutical use of echinacoside
05/25/2011CN101244104B Method for increasing rare saponin content in panax ginseng total saponin extract
05/25/2011CN101237870B Concomitant pharmaceutical agents and use thereof
05/25/2011CN101160120B Sedative effect-providing agent and sedative fragrance composition containing the same
05/25/2011CN101128431B Novel quinoline derivatives as potassium ion channel openers
05/25/2011CN101107998B Health-care food improving memorization and method of preparing the same
05/25/2011CN101062037B Process for their preparation of thioxanthine derivatives, their use
05/25/2011CN101052651B Caspase-2 inhibitors and their biological applications
05/25/2011CN101032267B Tea for dispelling the alcoholic intoxication
05/25/2011CN101023056B Levodopa prodrugs, and compositions and uses thereof
05/25/2011CN101014576B Aryl spirolactam cgrp receptor antagonists
05/24/2011US7947743 Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
05/24/2011US7947726 Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof
05/24/2011US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
05/24/2011US7947713 Tripeptidyl peptidase inhibitors
05/24/2011US7947697 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d] pyrazolo[1,5-a]pyrimidine methanesulfonate as a CRF antagonist
05/24/2011US7947689 Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators
05/24/2011US7947688 N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto
05/24/2011US7947684 anticoagulants; immunomoderators; antiinflammatory agents
05/24/2011US7947683 3-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptors
05/24/2011US7947678 Heterocyclic benzodiazepine CGRP receptor antagonists
05/24/2011US7947677 Spirolactam tricyclic CGRP receptor antagonists
05/24/2011US7947668 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
05/24/2011US7947498 Embryonic stem cells and neural progenitor cells derived therefrom
05/24/2011CA2633170C Butylphthalide intravenous emulsion and application thereof
05/24/2011CA2629466C Beta-secretase modulators and methods of use
05/24/2011CA2508194C Use of ibudilast as a phosphodiesterase 10a inhibitor
05/24/2011CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines
05/24/2011CA2471642C 6-fluorobicyclo[3.1.0]hexane derivatives
05/24/2011CA2467552C Nicotin-or isonicotin benzothiazole derivatives
05/24/2011CA2464358C Alkyl ether derivatives or their salts
05/24/2011CA2453901C Substituted 4-aminocyclohexanols
05/24/2011CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
05/24/2011CA2441235C Aryl and biaryl compounds having mch modulatory activity
05/24/2011CA2421562C A method of producing analgesia using sodium channel blocking compounds such as tetrodotoxin, saxitoxin and derivatives thereof
05/24/2011CA2412947C Method for treating a movement disorder